370 related articles for article (PubMed ID: 7649478)
1. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.
Köntgen F; Grumont RJ; Strasser A; Metcalf D; Li R; Tarlinton D; Gerondakis S
Genes Dev; 1995 Aug; 9(16):1965-77. PubMed ID: 7649478
[TBL] [Abstract][Full Text] [Related]
2. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor.
Gerondakis S; Strasser A; Metcalf D; Grigoriadis G; Scheerlinck JY; Grumont RJ
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3405-9. PubMed ID: 8622948
[TBL] [Abstract][Full Text] [Related]
3. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function.
Liou HC; Jin Z; Tumang J; Andjelic S; Smith KA; Liou ML
Int Immunol; 1999 Mar; 11(3):361-71. PubMed ID: 10221648
[TBL] [Abstract][Full Text] [Related]
4. Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-kappa B-inducing kinase.
Yamada T; Mitani T; Yorita K; Uchida D; Matsushima A; Iwamasa K; Fujita S; Matsumoto M
J Immunol; 2000 Jul; 165(2):804-12. PubMed ID: 10878354
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
[TBL] [Abstract][Full Text] [Related]
6. B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells.
Grumont RJ; Rourke IJ; O'Reilly LA; Strasser A; Miyake K; Sha W; Gerondakis S
J Exp Med; 1998 Mar; 187(5):663-74. PubMed ID: 9480976
[TBL] [Abstract][Full Text] [Related]
7. The subunit composition of NF-kappa B complexes changes during B-cell development.
Grumont RJ; Gerondakis S
Cell Growth Differ; 1994 Dec; 5(12):1321-31. PubMed ID: 7696180
[TBL] [Abstract][Full Text] [Related]
8. Multiple hemopoietic defects and lymphoid hyperplasia in mice lacking the transcriptional activation domain of the c-Rel protein.
Carrasco D; Cheng J; Lewin A; Warr G; Yang H; Rizzo C; Rosas F; Snapper C; Bravo R
J Exp Med; 1998 Apr; 187(7):973-84. PubMed ID: 9529314
[TBL] [Abstract][Full Text] [Related]
9. The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells.
Pohl T; Gugasyan R; Grumont RJ; Strasser A; Metcalf D; Tarlinton D; Sha W; Baltimore D; Gerondakis S
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4514-9. PubMed ID: 11930006
[TBL] [Abstract][Full Text] [Related]
10. The transcriptionally active factors mediating the effect of the HTLV-I Tax transactivator on the IL-2R alpha kappa B enhancer include the product of the c-rel proto-oncogene.
Crenon I; Béraud C; Simard P; Montagne J; Veschambre P; Jalinot P
Oncogene; 1993 Apr; 8(4):867-75. PubMed ID: 8455941
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.
Chen G; Hardy K; Bunting K; Daley S; Ma L; Shannon MF
J Immunol; 2010 Aug; 185(4):2350-9. PubMed ID: 20639489
[TBL] [Abstract][Full Text] [Related]
12. PU.1/Spi-B regulation of c-rel is essential for mature B cell survival.
Hu CJ; Rao S; Ramirez-Bergeron DL; Garrett-Sinha LA; Gerondakis S; Clark MR; Simon MC
Immunity; 2001 Oct; 15(4):545-55. PubMed ID: 11672537
[TBL] [Abstract][Full Text] [Related]
13. c-rel regulation of IL-2 gene expression may be mediated through activation of AP-1.
Shapiro VS; Mollenauer MN; Greene WC; Weiss A
J Exp Med; 1996 Nov; 184(5):1663-9. PubMed ID: 8920856
[TBL] [Abstract][Full Text] [Related]
14. Deficient translocation of c-Rel is associated with impaired Th1 cytokine production in T cells from atopic dermatitis patients.
Dieckhoff K; Graf P; Beinhauer B; Schwaerzler C; Carballido JM; Neumann C; Zachmann K; Jung T
Exp Dermatol; 2005 Jan; 14(1):17-25. PubMed ID: 15660915
[TBL] [Abstract][Full Text] [Related]
15. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kappa B binding site.
Capobianco AJ; Gilmore TD
Oncogene; 1991 Dec; 6(12):2203-10. PubMed ID: 1766669
[TBL] [Abstract][Full Text] [Related]
16. The murine c-rel proto-oncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli.
Grumont RJ; Gerondakis S
Oncogene Res; 1990; 5(4):245-54. PubMed ID: 2204017
[TBL] [Abstract][Full Text] [Related]
17. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis.
Grumont RJ; Rourke IJ; Gerondakis S
Genes Dev; 1999 Feb; 13(4):400-11. PubMed ID: 10049356
[TBL] [Abstract][Full Text] [Related]
18. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.
Bunting K; Rao S; Hardy K; Woltring D; Denyer GS; Wang J; Gerondakis S; Shannon MF
J Immunol; 2007 Jun; 178(11):7097-109. PubMed ID: 17513759
[TBL] [Abstract][Full Text] [Related]
20. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression.
Grossmann M; O'Reilly LA; Gugasyan R; Strasser A; Adams JM; Gerondakis S
EMBO J; 2000 Dec; 19(23):6351-60. PubMed ID: 11101508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
